CSNpharm

CSNpharm logo

Csnpharm is committed to providing you with high quality products and outstanding services. We supply over 5000 bioactive compounds in stock, including inhibitors, agonists and natural products for laboratory and scientific use. Csnpharm has always been committed to develop quality products that are validated by NMR, UPLC, LC-MS, GC, Chiral HPLC and so on. We have a professional technical support team for customer service with years of experience in life science. Csnpharm is your reliable partner for scientific research.

Company Website

Product Listing

Mirabegron 50mg  | ≥99%

CSNpharm

Mirabegron is an agonist of β3 adrenergic receptor with EC50 value of 22.4nM, used for the treatment of overactive bladder.

More Information Supplier Page

Miridesap 10mg  | ≥97%

CSNpharm

Miridesap is an antineoplastic which depletes circulating serum amyloid P component (SAP) almost completely but leaves some SAP in amyloid deposits for specific recognition by subsequently administered therapeutic anti-SAP antibodies.

More Information Supplier Page

Miridesap 5mg  | ≥97%

CSNpharm

Miridesap is an antineoplastic which depletes circulating serum amyloid P component (SAP) almost completely but leaves some SAP in amyloid deposits for specific recognition by subsequently administered therapeutic anti-SAP antibodies.

More Information Supplier Page

Miriplatin 50mg  | ≥98%

CSNpharm

Miriplatin is a platinum complex used in TACE that shows promise for the treatment of hepatocellular carcinoma (HCC).

More Information Supplier Page

Miriplatin 100mg  | ≥98%

CSNpharm

Miriplatin is a platinum complex used in TACE that shows promise for the treatment of hepatocellular carcinoma (HCC).

More Information Supplier Page

Miriplatin 5mg  | ≥98%

CSNpharm

Miriplatin is a platinum complex used in TACE that shows promise for the treatment of hepatocellular carcinoma (HCC).

More Information Supplier Page

Miriplatin 10mg  | ≥98%

CSNpharm

Miriplatin is a platinum complex used in TACE that shows promise for the treatment of hepatocellular carcinoma (HCC).

More Information Supplier Page

Misoprostol 100mg  | ≥98%

CSNpharm

Misoprostol is a synthetic prostaglandin E1 (PGE1) analog that is used to prevent gastric ulcers, to treat missed miscarriage, to induce labor, and to induce abortion.

More Information Supplier Page

Misoprostol 10mg  | ≥98%

CSNpharm

Misoprostol is a synthetic prostaglandin E1 (PGE1) analog that is used to prevent gastric ulcers, to treat missed miscarriage, to induce labor, and to induce abortion.

More Information Supplier Page

Misoprostol 50mg  | ≥98%

CSNpharm

Misoprostol is a synthetic prostaglandin E1 (PGE1) analog that is used to prevent gastric ulcers, to treat missed miscarriage, to induce labor, and to induce abortion.

More Information Supplier Page

Misoprostol 5mg  | ≥98%

CSNpharm

Misoprostol is a synthetic prostaglandin E1 (PGE1) analog that is used to prevent gastric ulcers, to treat missed miscarriage, to induce labor, and to induce abortion.

More Information Supplier Page

Misoprostol 25mg  | ≥98%

CSNpharm

Misoprostol is a synthetic prostaglandin E1 (PGE1) analog that is used to prevent gastric ulcers, to treat missed miscarriage, to induce labor, and to induce abortion.

More Information Supplier Page

Mitiglinide Calcium 100mg  | ≥99%

CSNpharm

Mitiglinide calcium is a blood glucose-lowering drugs, stimulating insulin secretion by closing the ATP-sensitive K+ channels in pancreatic beta-cells.

More Information Supplier Page

Mitiglinide Calcium 250mg  | ≥99%

CSNpharm

Mitiglinide calcium is a blood glucose-lowering drugs, stimulating insulin secretion by closing the ATP-sensitive K+ channels in pancreatic beta-cells.

More Information Supplier Page

Mitiglinide Calcium 25mg  | ≥99%

CSNpharm

Mitiglinide calcium is a blood glucose-lowering drugs, stimulating insulin secretion by closing the ATP-sensitive K+ channels in pancreatic beta-cells.

More Information Supplier Page

MitMAB 5g  | ≥98%

CSNpharm

MitMAB is the dynamin I inhibitor with IC50 of 3.1 µM and Ki of 940 nM. It can block the dynamin-phospholipid interaction.

More Information Supplier Page

MitMAB 1g  | ≥98%

CSNpharm

MitMAB is the dynamin I inhibitor with IC50 of 3.1 µM and Ki of 940 nM. It can block the dynamin-phospholipid interaction.

More Information Supplier Page

Mitotane 100mg  | ≥99%

CSNpharm

Mitotane is a steroidogenesis inhibitor and cytostatic antineoplastic medication which is used in the treatment of adrenocortical carcinoma and Cushing’s syndrome.

More Information Supplier Page

Mitoxantrone 10mg  | ≥98%

CSNpharm

Mitoxantrone is a type II topoisomerase inhibitor with IC50 of 2.0 μM, 0.42 mM for HepG2 and MCF-7/wt cells, respectively.

More Information Supplier Page

Mitoxantrone 100mg  | ≥98%

CSNpharm

Mitoxantrone is a type II topoisomerase inhibitor with IC50 of 2.0 μM, 0.42 mM for HepG2 and MCF-7/wt cells, respectively.

More Information Supplier Page

Mitoxantrone 50mg  | ≥98%

CSNpharm

Mitoxantrone is a type II topoisomerase inhibitor with IC50 of 2.0 μM, 0.42 mM for HepG2 and MCF-7/wt cells, respectively.

More Information Supplier Page

MIV-150 1mg  | ≥98%

CSNpharm

MIV-150 is a tight-binding, allosteric inhibitor of reverse transcriptase that is active against HIV-1 and HIV-2 (both EC50s = 1 nM in vitro).

More Information Supplier Page

Mizoribine 5mg  | ≥99%

CSNpharm

Mizoribine is an immunosuppressive agents (IC50=100 μM) that inhibit the proliferation of lymphocytes selectively, via inhibition of IMPDH.

More Information Supplier Page

Mizoribine 100mg  | ≥99%

CSNpharm

Mizoribine is an immunosuppressive agents (IC50=100 μM) that inhibit the proliferation of lymphocytes selectively, via inhibition of IMPDH.

More Information Supplier Page

Mizoribine 10mg  | ≥99%

CSNpharm

Mizoribine is an immunosuppressive agents (IC50=100 μM) that inhibit the proliferation of lymphocytes selectively, via inhibition of IMPDH.

More Information Supplier Page

Mizoribine 50mg  | ≥99%

CSNpharm

Mizoribine is an immunosuppressive agents (IC50=100 μM) that inhibit the proliferation of lymphocytes selectively, via inhibition of IMPDH.

More Information Supplier Page

MK 0343 25mg  | ≥99%

CSNpharm

MK 0343 is a selective partial agonist of GABAAα3, α1, α5 and α2 with Ki values of 0.21 nM-0.40 nM. It displays anxiolytic activity in rodent and primate models.

More Information Supplier Page

MK 0343 1mg  | ≥99%

CSNpharm

MK 0343 is a selective partial agonist of GABAAα3, α1, α5 and α2 with Ki values of 0.21 nM-0.40 nM. It displays anxiolytic activity in rodent and primate models.

More Information Supplier Page

MK 0343 10mg  | ≥99%

CSNpharm

MK 0343 is a selective partial agonist of GABAAα3, α1, α5 and α2 with Ki values of 0.21 nM-0.40 nM. It displays anxiolytic activity in rodent and primate models.

More Information Supplier Page

MK 0343 5mg  | ≥99%

CSNpharm

MK 0343 is a selective partial agonist of GABAAα3, α1, α5 and α2 with Ki values of 0.21 nM-0.40 nM. It displays anxiolytic activity in rodent and primate models.

More Information Supplier Page

MK 0557 50mg  | ≥98%

CSNpharm

MK-0557 is a highly selective, orally available neuropeptide Y5 receptor antagonist with a Ki of 1.6 nM.

More Information Supplier Page

MK 0557 250mg  | ≥98%

CSNpharm

MK-0557 is a highly selective, orally available neuropeptide Y5 receptor antagonist with a Ki of 1.6 nM.

More Information Supplier Page

MK 0557 5mg  | ≥98%

CSNpharm

MK-0557 is a highly selective, orally available neuropeptide Y5 receptor antagonist with a Ki of 1.6 nM.

More Information Supplier Page

MK 0557 25mg  | ≥98%

CSNpharm

MK-0557 is a highly selective, orally available neuropeptide Y5 receptor antagonist with a Ki of 1.6 nM.

More Information Supplier Page

MK 0557 10mg  | ≥98%

CSNpharm

MK-0557 is a highly selective, orally available neuropeptide Y5 receptor antagonist with a Ki of 1.6 nM.

More Information Supplier Page

MK 0557 100mg  | ≥98%

CSNpharm

MK-0557 is a highly selective, orally available neuropeptide Y5 receptor antagonist with a Ki of 1.6 nM.

More Information Supplier Page